NEWS
Follow us on twitter: @csjmagazine
Gender-blind blood transfusion does not increase risk of death
In a study published in the journal Circulation researchers from Karolinska Institutet and Lund University examined how sex-discordant blood transfusions (i.e. blood from a woman to a man or vice versa) affected survival following cardiac surgery. The study was conducted on data from the SWEDEHEART registry and the SCANDAT2 database on almost 50,000 patients who underwent cardiac surgery from 1997 to 2012 in Sweden. This study was done after a previous Swedish study indicated a possible increased risk of death after cardiac surgery from sex-discordant blood transfusions. “The consequences of the findings from this first study, if proved true, would have been
however, the team found no association between sex-discordant blood transfusions and post-cardiac surgery survival. Martin Holzmann, lead author of the new study continued: “Our results clearly show that there is no real connection between sex-discordant blood transfusions and the risk of death.”
immense and necessitated radical changes to how blood transfusions are managed around the world,” said Martin Holzmann from Karolinska Institutet. In the new study,
The reason for the difference between the studies is that the new one fully compensated for the fact that more transfusions increase the risk of death and of a mismatch between the sex of the donor and the patient. The researchers conclude from their results that current gender-blind blood transfusion procedures are safe and do not need changing.
Solving your challenges - today and tomorrow
NEWS IN BRIEF Safety alert
Being at the forefront of innovation, your challenges set our agenda. The healthcare industry is facing increasing demands on delivering more for less, and increasing expectations on maintaining and improving quality of the daily operations. We are here to support with solutions facilitating the daily operations, today and tomorrow. We aim to enable you to get accurate results and improved efficiency, while taking care of staff and patients.
We set the standards as a leading provider of infection control solutions.
A patient safety alert has been issued to warn NHS providers of the risk of severe harm and death if an insulin needle and syringe is used to administer insulin withdrawn directly from a pen device or replacement cartridge. Patient safety concerns have been identified where healthcare professionals use an insulin syringe and needle to withdraw medication directly from a patient’s insulin pen device. This practice should not happen as the strength of insulin in pen devices varies, creating a risk of overdose if the strength is not taken into consideration when determining the volume required. The alert asks providers to ensure staff have access to appropriate equipment and training for administering insulin using a pen device. Visit: https://
improvement.nhs.uk/uploads/documents/ Patient_Safety_Alert_-_Withdrawing_insulin _from_pen_devices.pdf
IPS awards
The Infection Prevention Society annual awards programme offers the opportunity to recognise and celebrate excellence in infection prevention and control. The categories include: l IPS Practitioner of the Year. l IPS Team of the Year sponsored by Daniels Healthcare.
l IPS Branch of the Year. l IPS Link Practitioner of the Year.
www.getingegroup.com
Getinge UK Ltd, Unit 17, The Village, South Normanton, Derbyshire DE55 2DS 01332 861665
ukhcsales@getinge.com
The Awards application process is simple with completion of a short online entry form (
www.ips.uk.net/IPSAwards ). The closing date for receipt of completed applications is midnight on Friday 9th June 2017.
12 I
WWW.CLINICALSERVICESJOURNAL.COM FEBRUARY 2017
© Vladimir Mucibabic - Fotolia/Adobe Stock.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
